Chemo-enzymatic reactions have received great attention
for asymmetric
synthesis, but most reported systems use only one- or two-step enzymatic
reactions for relatively simple functionalization and are based on
a chemo-enzyme sequence, which is limited by the substrate scope of
enzymes. Herein, we report a “multienzyme cascadechemocatalysis”
concept via an enzyme-chemo sequence for complex asymmetric functionalization
of simple substrates by integrating multistep biocascades to introduce
functionality and enantioselectivity, with robust chemocatalysis to
diversify the product scope. The concept was successfully demonstrated
through the enantiodivergent synthesis of 12 structurally diverse
(S)- and (R)-2-biarylpropanoic acids
(94–97% ee; up to >99% conversion) from easily available
aryl
alkenes by engineering epoxidation–isomerization–oxidation
biocascades containing enantio-complementary enzymes and combining
with Pd-catalyzed cross-coupling. The enzyme-chemical strategy was
extended to the high-yielding synthesis of NSAID drugs (S)-flurbiprofen, (S)-ketoprofen, and felbinac. This
concept enables streamlined synthetic routes that are inaccessible
by each type of catalyst alone or a chemo-enzyme sequence.